Medpace Stock Price, News & Analysis (NASDAQ:MEDP)

$37.60 -0.43 (-1.13 %)
(As of 02/22/2018 04:10 AM ET)
Previous Close$37.60
Today's Range$37.13 - $38.38
52-Week Range$21.76 - $39.64
Volume274,900 shs
Average Volume177,622 shs
Market Capitalization$1.43 billion
P/E Ratio55.29
Dividend YieldN/A
Beta-0.76

About Medpace (NASDAQ:MEDP)

Medpace logoMedpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Receive MEDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MEDP
CUSIPN/A
Phone513-579-9911

Debt

Debt-to-Equity Ratio0.36%
Current Ratio0.68%
Quick Ratio0.68%

Price-To-Earnings

Trailing P/E Ratio55.2941176470588
Forward P/E Ratio25.07
P/E Growth1.62

Sales & Book Value

Annual Sales$421.58 million
Price / Sales3.35
Cash Flow$2.74 per share
Price / Cash13.71
Book Value$15.00 per share
Price / Book2.51

Profitability

Trailing EPS$0.68
Net Income$13.42 million
Net Margins6.44%
Return on Equity10.00%
Return on Assets6.19%

Miscellaneous

Employees2,500
Outstanding Shares37,580,000

Medpace (NASDAQ:MEDP) Frequently Asked Questions

What is Medpace's stock symbol?

Medpace trades on the NASDAQ under the ticker symbol "MEDP."

How were Medpace's earnings last quarter?

Medpace Holdings Inc (NASDAQ:MEDP) issued its earnings results on Monday, October, 30th. The company reported $0.40 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.36 by $0.04. The company earned $98.68 million during the quarter, compared to the consensus estimate of $96.84 million. Medpace had a return on equity of 10.00% and a net margin of 6.44%. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.40 EPS. View Medpace's Earnings History.

When will Medpace make its next earnings announcement?

Medpace is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Medpace.

Where is Medpace's stock going? Where will Medpace's stock price be in 2018?

7 brokers have issued 1-year target prices for Medpace's shares. Their forecasts range from $34.00 to $38.00. On average, they anticipate Medpace's share price to reach $35.75 in the next year. View Analyst Ratings for Medpace.

What are Wall Street analysts saying about Medpace stock?

Here are some recent quotes from research analysts about Medpace stock:

  • 1. According to Zacks Investment Research, "Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. " (12/13/2017)
  • 2. Jefferies Group LLC analysts commented, "Medpace boasts eye-popping margin, strong cash flow, and an enticing correlation to fast growing biotech customers. With its group-high valuation, MEDP's risk, in our view, is that investors have looked through management's "conservative" guidance to upsides, akin to prior CRO post-IPO performances. 1.05x BtB, lower 2017 revenue guidance, and in-line EPS will likely pressure the stock a little on Tuesday." (2/28/2017)

Who are some of Medpace's key competitors?

Who are Medpace's key executives?

Medpace's management team includes the folowing people:

  • August J. Troendle M.D., Chairman of the Board, President, Chief Executive Officer (Age 60)
  • Jesse J. Geiger CPA, Chief Financial Officer, Chief Operating Officer - Laboratory Operations (Age 42)
  • Susan E. Burwig, Executive Vice President - Operations (Age 54)
  • Penelope J. Bucknell, Vice President - Human Resources (Age 58)
  • Stephen P. Ewald J.D., General Counsel, Corporate Secretary (Age 47)
  • Anastasya Molodykh, Director
  • John R. Richardson, Director
  • Bruce Brown, Independent Director (Age 59)
  • Brian T. Carley, Independent Director (Age 63)
  • Robert O. Kraft, Independent Director (Age 47)

When did Medpace IPO?

(MEDP) raised $150 million in an initial public offering on Thursday, August 11th 2016. The company issued 7,000,000 shares at $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns Medpace stock?

Medpace's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.99%), Acadian Asset Management LLC (1.69%), Granite Investment Partners LLC (0.71%), Cardinal Capital Management LLC CT (0.63%), Two Sigma Investments LP (0.54%) and Monashee Investment Management LLC (0.53%). Company insiders that own Medpace stock include August J Troendle, Medpace Limited Partnership and Susan E Burwig. View Institutional Ownership Trends for Medpace.

Who sold Medpace stock? Who is selling Medpace stock?

Medpace's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Granite Investment Partners LLC, Alambic Investment Management L.P., Citadel Advisors LLC, Convergence Investment Partners LLC and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Medpace.

Who bought Medpace stock? Who is buying Medpace stock?

Medpace's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Cardinal Capital Management LLC CT, Monashee Investment Management LLC, Two Sigma Investments LP, Mackenzie Financial Corp, Renaissance Technologies LLC, Endurant Capital Management LP and Thrivent Financial For Lutherans. Company insiders that have bought Medpace stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace.

How do I buy Medpace stock?

Shares of Medpace can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medpace's stock price today?

One share of Medpace stock can currently be purchased for approximately $37.60.

How big of a company is Medpace?

Medpace has a market capitalization of $1.43 billion and generates $421.58 million in revenue each year. The company earns $13.42 million in net income (profit) each year or $0.68 on an earnings per share basis. Medpace employs 2,500 workers across the globe.

How can I contact Medpace?

Medpace's mailing address is 5375 MEDPACE WAY, CINCINNATI OH, 45227. The company can be reached via phone at 513-579-9911 or via email at [email protected]


MarketBeat Community Rating for Medpace (MEDP)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  110 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  211
MarketBeat's community ratings are surveys of what our community members think about Medpace and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medpace (NASDAQ:MEDP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.142.142.142.50
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $35.75$35.75$35.75$34.00
Price Target Upside: 4.59% downside4.59% downside4.59% downside14.48% upside

Medpace (NASDAQ:MEDP) Consensus Price Target History

Price Target History for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/1/2017Jefferies GroupBoost Price TargetHold$34.00 -> $38.00N/AView Rating Details
11/1/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/31/2017Robert W. BairdBoost Price TargetNeutral$32.00 -> $35.00N/AView Rating Details
10/17/2017KeyCorpReiterated RatingHoldN/AView Rating Details
9/29/2017Raymond James FinancialInitiated CoverageMkt Perform -> Market PerformLowView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingOutperform$35.00 -> $36.00LowView Rating Details
5/3/2017Wells Fargo & CoDowngradeOutperform -> Market PerformHighView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Medpace (NASDAQ:MEDP) Earnings History and Estimates Chart

Earnings by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ MEDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$0.38N/AView Earnings Details
10/30/2017Q3 2017$0.36$0.40$96.84 million$98.68 millionViewN/AView Earnings Details
7/31/2017Q2 2017$0.30$0.38$92.71 million$94.60 millionViewN/AView Earnings Details
5/1/2017Q1 2017$0.37$0.34$93.61 million$93.80 millionViewListenView Earnings Details
2/27/2017Q416$0.34$0.35$94.40 million$95.38 millionViewListenView Earnings Details
11/3/2016Q316$0.34$0.40$91.42 million$94.80 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Medpace (NASDAQ:MEDP) Earnings Estimates

2018 EPS Consensus Estimate: $1.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.40$0.47$0.43
Q2 20183$0.42$0.49$0.45
Q3 20183$0.44$0.52$0.47
Q4 20183$0.46$0.53$0.48
Q1 20191$0.45$0.45$0.45
Q2 20191$0.46$0.46$0.46
Q3 20191$0.50$0.50$0.50
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Medpace (NASDAQ:MEDP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Medpace (NASDAQ MEDP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 25.80%
Institutional Ownership Percentage: 20.71%
Insider Trades by Quarter for Medpace (NASDAQ:MEDP)
Institutional Ownership by Quarter for Medpace (NASDAQ:MEDP)

Medpace (NASDAQ MEDP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2017Medpace Limited PartnershipMajor ShareholderSell4,600,000$30.16$138,736,000.00View SEC Filing  
8/22/2017Medpace Limited PartnershipMajor ShareholderSell2,000,000$30.27$60,540,000.00View SEC Filing  
8/18/2016August J TroendleCEOBuy10,000$27.98$279,800.001,221,416View SEC Filing  
8/17/2016Susan E BurwigInsiderBuy19,211$29.21$561,153.311,211View SEC Filing  
8/16/2016August J TroendleCEOBuy869,565$23.00$19,999,995.001,221,416View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medpace (NASDAQ MEDP) News Headlines

Source:
DateHeadline
Medpace (MEDP) Scheduled to Post Earnings on MondayMedpace (MEDP) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - February 19 at 5:22 AM
Medpace (MEDP) Upgraded at BidaskClubMedpace (MEDP) Upgraded at BidaskClub
www.americanbankingnews.com - February 17 at 2:10 PM
Zacks: Analysts Anticipate Medpace Holdings Inc (MEDP) Will Post Earnings of $0.39 Per ShareZacks: Analysts Anticipate Medpace Holdings Inc (MEDP) Will Post Earnings of $0.39 Per Share
www.americanbankingnews.com - February 15 at 1:36 PM
Medpace Holdings Inc (MEDP) Given Average Recommendation of "Hold" by BrokeragesMedpace Holdings Inc (MEDP) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 14 at 3:36 AM
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on February 26, 2018Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on February 26, 2018
finance.yahoo.com - February 5 at 4:37 PM
Will Higher Membership, Revenues Aid Cigna (CI) Q4 Earnings?Will Higher Membership, Revenues Aid Cigna (CI) Q4 Earnings?
www.nasdaq.com - January 31 at 9:05 AM
Medpace Holdings Inc (MEDP) Expected to Post Quarterly Sales of $97.44 MillionMedpace Holdings Inc (MEDP) Expected to Post Quarterly Sales of $97.44 Million
www.americanbankingnews.com - January 31 at 3:52 AM
See what the IHS Markit Score report has to say about Medpace Holdings Inc.See what the IHS Markit Score report has to say about Medpace Holdings Inc.
finance.yahoo.com - January 30 at 9:14 AM
 Brokerages Expect Medpace Holdings Inc (MEDP) to Announce $0.39 EPS Brokerages Expect Medpace Holdings Inc (MEDP) to Announce $0.39 EPS
www.americanbankingnews.com - January 29 at 1:14 PM
Medpace Holdings Inc (MEDP) Receives Average Rating of "Hold" from AnalystsMedpace Holdings Inc (MEDP) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 20 at 4:02 AM
Critical Review: Blueprint Medicines (BPMC) vs. Medpace (MEDP)Critical Review: Blueprint Medicines (BPMC) vs. Medpace (MEDP)
www.americanbankingnews.com - January 17 at 3:12 AM
FY2018 Earnings Forecast for Medpace Holdings Inc (MEDP) Issued By William BlairFY2018 Earnings Forecast for Medpace Holdings Inc (MEDP) Issued By William Blair
www.americanbankingnews.com - January 15 at 10:54 AM
$97.42 Million in Sales Expected for Medpace Holdings Inc (MEDP) This Quarter$97.42 Million in Sales Expected for Medpace Holdings Inc (MEDP) This Quarter
www.americanbankingnews.com - January 14 at 6:30 AM
$0.39 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter$0.39 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter
www.americanbankingnews.com - January 12 at 3:26 PM
Q1 2018 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William BlairQ1 2018 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William Blair
www.americanbankingnews.com - January 12 at 9:34 AM
Q4 2017 EPS Estimates for Medpace Holdings Inc Boosted by Analyst (MEDP)Q4 2017 EPS Estimates for Medpace Holdings Inc Boosted by Analyst (MEDP)
www.americanbankingnews.com - January 8 at 3:54 AM
Medpace Holdings Inc (MEDP) Sees Large Decline in Short InterestMedpace Holdings Inc (MEDP) Sees Large Decline in Short Interest
www.americanbankingnews.com - January 1 at 1:16 AM
$97.43 Million in Sales Expected for Medpace Holdings Inc (MEDP) This Quarter$97.43 Million in Sales Expected for Medpace Holdings Inc (MEDP) This Quarter
www.americanbankingnews.com - December 29 at 9:56 PM
$0.38 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter$0.38 Earnings Per Share Expected for Medpace Holdings Inc (MEDP) This Quarter
www.americanbankingnews.com - December 27 at 1:08 AM
Medpace Holdings Inc (MEDP) Given Consensus Recommendation of "Hold" by BrokeragesMedpace Holdings Inc (MEDP) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 26 at 4:34 AM
Medpace (MEDP) Lifted to Buy at Zacks Investment ResearchMedpace (MEDP) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - December 17 at 9:24 AM
BidaskClub Upgrades Medpace (MEDP) to BuyBidaskClub Upgrades Medpace (MEDP) to Buy
www.americanbankingnews.com - December 17 at 12:50 AM
Reviewing Galapagos (GLPG) & Medpace (MEDP)Reviewing Galapagos (GLPG) & Medpace (MEDP)
www.americanbankingnews.com - December 15 at 3:10 AM
Will Medpace Holdings Inc (undefined:MEDP) Continue To Underperform Its Industry?Will Medpace Holdings Inc (undefined:MEDP) Continue To Underperform Its Industry?
finance.yahoo.com - December 13 at 5:48 PM
 Analysts Anticipate Medpace Holdings Inc (MEDP) Will Announce Quarterly Sales of $97.43 Million Analysts Anticipate Medpace Holdings Inc (MEDP) Will Announce Quarterly Sales of $97.43 Million
www.americanbankingnews.com - December 11 at 9:50 AM
Medpace (MEDP) Downgraded to "Sell" at BidaskClubMedpace (MEDP) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - December 11 at 12:52 AM
Medpace Holdings Inc (MEDP) Major Shareholder Medpace Limited Partnership Sells 4,600,000 SharesMedpace Holdings Inc (MEDP) Major Shareholder Medpace Limited Partnership Sells 4,600,000 Shares
www.americanbankingnews.com - December 7 at 5:28 PM
Free Post Earnings Research Report: Medpace’ EPS Soared 92%Free Post Earnings Research Report: Medpace’ EPS Soared 92%
finance.yahoo.com - December 5 at 9:50 AM
Medpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Hold" from BrokeragesMedpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 1 at 6:15 AM
Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : November 30, 2017Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : November 30, 2017
finance.yahoo.com - November 30 at 9:19 AM
Medpace Holdings (MEDP) Announces 4M Share Secondary OfferingMedpace Holdings (MEDP) Announces 4M Share Secondary Offering
www.streetinsider.com - November 28 at 10:08 AM
Medpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling ShareholderMedpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder
finance.yahoo.com - November 27 at 4:58 PM
Medpace Holdings, Inc. (MEDP) Stock Rating Lowered by Zacks Investment ResearchMedpace Holdings, Inc. (MEDP) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 25 at 10:12 PM
$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - November 23 at 10:22 AM
Zacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPSZacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPS
www.americanbankingnews.com - November 21 at 1:26 PM
ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017
finance.yahoo.com - November 17 at 3:57 PM
Medpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from BrokeragesMedpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 3:46 AM
Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 3 at 5:18 PM
ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017
finance.yahoo.com - November 3 at 5:18 PM
 Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million
www.americanbankingnews.com - November 3 at 10:51 AM
Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)
www.americanbankingnews.com - November 2 at 8:53 AM
FY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William BlairFY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William Blair
www.americanbankingnews.com - November 2 at 8:53 AM
Equities Analysts Set Expectations for Medpace Holdings Incs FY2017 Earnings (MEDP)Equities Analysts Set Expectations for Medpace Holdings Inc's FY2017 Earnings (MEDP)
www.americanbankingnews.com - November 2 at 8:52 AM
Analysts Issue Forecasts for Medpace Holdings, Inc.s Q1 2018 Earnings (MEDP)Analysts Issue Forecasts for Medpace Holdings, Inc.'s Q1 2018 Earnings (MEDP)
www.americanbankingnews.com - November 1 at 2:04 PM
William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)
www.americanbankingnews.com - November 1 at 9:18 AM
Edited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMTEdited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMT
finance.yahoo.com - November 1 at 6:10 AM
Medpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. BairdMedpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. Baird
www.americanbankingnews.com - October 31 at 10:48 AM
Medpace Holdings, Inc. (MEDP) Issues Quarterly  Earnings Results, Beats Estimates By $0.04 EPSMedpace Holdings, Inc. (MEDP) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - October 31 at 8:56 AM
Medpace Holdings, Inc. Reports Third Quarter 2017 ResultsMedpace Holdings, Inc. Reports Third Quarter 2017 Results
finance.yahoo.com - October 31 at 5:16 AM
Medpace beats Street 3Q forecastsMedpace beats Street 3Q forecasts
finance.yahoo.com - October 31 at 5:16 AM

SEC Filings

Medpace (NASDAQ:MEDP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medpace (NASDAQ:MEDP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medpace (NASDAQ MEDP) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.